BMSSC
PACB icon

B. Metzler seel. Sohn & Co’s Pacific Biosciences PACB Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,521
Closed -$442K – 759
2022
Q1 		$442K Buy
+48,521
New +$559K 0.01% 622

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

B. Metzler seel. Sohn & Co's PACB Position: Q2 2022 in Review

B. Metzler seel. Sohn & Co sold out of Pacific Biosciences (PACB) in Q2 2022, closing a stake of 48,521 shares — an estimated $442K sold.

B. Metzler seel. Sohn & Co first reported a position in PACB in Q1 2022 and held it in 1 quarter. The position peaked at $442K in Q1 2022. 229 funds tracked by Wall St. Rank hold PACB as of Q2 2022.

  • B. Metzler seel. Sohn & Co reported no remaining Pacific Biosciences position as of Q2 2022 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 48,521 Pacific Biosciences shares in Q2 2022, an estimated $442K.
  • B. Metzler seel. Sohn & Co first reported a position in Pacific Biosciences in Q1 2022 and held it in 1 quarter.
  • B. Metzler seel. Sohn & Co's Pacific Biosciences position peaked at $442K in Q1 2022.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2022.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2022, filed 12 Aug 2022.